Related Articles
Methylation and decreased expression of SHP-1 are related to disease progression in chronic myelogenous leukemia
Rapamycin provides a therapeutic option through inhibition of mTOR signaling in chronic myelogenous leukemia
Lithium chloride attenuates the abnormal osteogenic/adipogenic differentiation of bone marrow-derived mesenchymal stem cells obtained from rats with steroid-related osteonecrosis by activating the β-catenin pathway
Induction of molecular remission by donor peripheral blood leukocyte therapy in patients relapsing with extramedullary blastic phase chronic myeloid leukemia after allogeneic bone marrow transplantation.
Expression and role of fibroblast activation protein α in acute myeloid leukemia